These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15803143

  • 1. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
    Lichtor T, Glick RP, Lin H, O-Sullivan I, Cohen EP.
    Cancer Gene Ther; 2005 Aug; 12(8):708-14. PubMed ID: 15803143
    [Abstract] [Full Text] [Related]

  • 2. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.
    de Zoeten E, Carr-Brendel V, Markovic D, Taylor-Papadimitriou J, Cohen EP.
    J Immunol; 1999 Jun 01; 162(11):6934-41. PubMed ID: 10352316
    [Abstract] [Full Text] [Related]

  • 3. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
    Kim TS, Jung MY, Cho D, Cohen EP.
    Vaccine; 2006 Oct 30; 24(42-43):6564-73. PubMed ID: 16837111
    [Abstract] [Full Text] [Related]

  • 4. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
    Lichtor T, Glick RP, Feldman LA, Osawa G, Hardman J, O- Sullivan I, Cohen EP.
    J Immunother; 2008 Jan 30; 31(1):18-27. PubMed ID: 18157008
    [Abstract] [Full Text] [Related]

  • 5. Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.
    Sung Kim T, Cohen EP.
    Cancer Gene Ther; 2005 Nov 30; 12(11):890-9. PubMed ID: 15905859
    [Abstract] [Full Text] [Related]

  • 6. An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants.
    de Zoeten EF, Markovic D, Cohen EP.
    Gene Ther; 2002 Sep 30; 9(17):1163-72. PubMed ID: 12170380
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
    O-Sullivan I, Kim TS, Chopra A, Cohen EP.
    Anticancer Res; 2006 Sep 30; 26(2A):873-84. PubMed ID: 16619482
    [Abstract] [Full Text] [Related]

  • 8. Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.
    Lichtor T, Glick RP, Tarlock K, Moffett S, Mouw E, Cohen EP.
    Cancer Gene Ther; 2002 May 30; 9(5):464-9. PubMed ID: 11961669
    [Abstract] [Full Text] [Related]

  • 9. Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cells.
    Kim TS, Chopra A, O-Sullivan IS, Cohen EP.
    J Immunother; 2006 May 30; 29(3):261-73. PubMed ID: 16699369
    [Abstract] [Full Text] [Related]

  • 10. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
    de Zoeten EF, Carr-Brendel V, Cohen EP.
    J Immunol; 1998 Mar 15; 160(6):2915-22. PubMed ID: 9510195
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice.
    Sun T, Kim TS, Waltz MR, Cohen EP.
    Cancer Gene Ther; 1995 Sep 15; 2(3):183-90. PubMed ID: 8528961
    [Abstract] [Full Text] [Related]

  • 12. Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant.
    Aruga A, Aruga E, Chang AE.
    Cancer Res; 1997 Aug 01; 57(15):3230-7. PubMed ID: 9242454
    [Abstract] [Full Text] [Related]

  • 13. Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in mice.
    O-Sullivan I, Chopra A, Carr J, Kim TS, Cohen EP.
    Cancer Res; 2008 Apr 01; 68(7):2463-70. PubMed ID: 18381455
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells.
    Kinoshita Y, Kono T, Yasumoto R, Kishimoto T, Wang CY, Haas GP, Nishisaka N.
    J Immunother; 2001 Apr 01; 24(3):205-11. PubMed ID: 11394497
    [Abstract] [Full Text] [Related]

  • 15. Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.
    Chen SA, Tsai MH, Wu FT, Hsiang A, Chen YL, Lei HY, Tzai TS, Leung HW, Jin YT, Hsieh CL, Hwang LH, Lai MD.
    Clin Cancer Res; 2000 Nov 01; 6(11):4381-8. PubMed ID: 11106257
    [Abstract] [Full Text] [Related]

  • 16. [Application of a tumor cell vaccine transfected with GM-CSF/IL-2 fusion gene for specific immunotherapy of hepatocellular carcinoma].
    Guo C, Liu QG, Yang W, Yao YM.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 01; 28(2):188-92. PubMed ID: 18250039
    [Abstract] [Full Text] [Related]

  • 17. Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanoma.
    Sun T, Carr-Brendel V, De Zoeten EF, Cohen EP.
    Cancer Gene Ther; 1998 Feb 01; 5(2):110-8. PubMed ID: 9570302
    [Abstract] [Full Text] [Related]

  • 18. Immunity to murine breast cancer cells modified to express MUC-1, a human breast cancer antigen, in transgenic mice tolerant to human MUC-1.
    Carr-Brendel V, Markovic D, Ferrer K, Smith M, Taylor-Papadimitriou J, Cohen EP.
    Cancer Res; 2000 May 01; 60(9):2435-43. PubMed ID: 10811121
    [Abstract] [Full Text] [Related]

  • 19. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP, Lichtor T, Lin H, Tarlock K, Cohen EP.
    J Neurosurg; 2006 Jul 01; 105(1 Suppl):65-70. PubMed ID: 16871873
    [Abstract] [Full Text] [Related]

  • 20. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.
    Cancer Gene Ther; 2000 Sep 01; 7(9):1279-85. PubMed ID: 11023201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.